P&T
Our
Other
Journal
MediMedia Managed Markets

 

Peer-Reviewed Articles from Managed Care

Research Articles from Managed Care

Sara L. Thier, MPH ; Kristina S. Yu-Isenberg, PhD, MPH, RPh ; Brian F. Leas, MS, MA ; C. Ron Cantrell, PhD ; Sandra DeBussey
A widespread approach that incorporates various stakeholders may be necessary to change adherence behavior
Mary V. Mason, MD, MBA ; Kara M. House, MBA ; Janice Linehan, PA-C, MHP ; Carol A. Speers, RN ; Lisa M. Joseph, RN, MBA
Cyril F. Chang, PhD
The old TennCare program had many flaws and detractors. Its near collapse led to a more realistic approach to providing coverage to the uninsured in Tennessee.
Gary R. Bazalo, MS ; Ashish V. Joshi, PhD ; John Germak, MD
Payers' drug costs for human growth hormone are related to product waste that is related to the container in which the product is supplied
Meredith Y. Smith, PhD ; Jerry Cromwell, PhD ; Judith DePue, EdD ; Bonnie Spring, PhD ; William Redd, PhD
Jill Karpel, MD ; Donald A. Bukstein, MD ; Robert LoNigro, MD
Management of the uncontrolled asthma patient and case examples
Therese Zink, MD, MPH ; Karen Lloyd, PhD, LP ; George Isham, MD ; David J. Mathews, PsyD, LICSW ; Terry Crowson, MD
Implementing what was formerly called the Chronic Care Model can improve an organization's response to this widespread problem
Joseph Flood, MD, FACR ; Charles Mihalik, PharmD, RPh ; Renee R. Fleming, RPh, MBA ; Bruce E. Strober, MD, PhD ; Deborah R. Zucker, MD, PhD
Heinz Nagel, MD ; Thomas Baehring, PhD ; Werner A. Scherbaum, MD, PhD
Germany has been able to enroll more than a million people with type 2 diabetes in DM programs through legislation that created incentives for physicians and insurers
Joseph A. Caprini, MD, MS, FACS, RVT ; Thomas M. Hyers, MD, FCCP
Deeply held, but not evidence-based, concerns about the possible risks of pharmacologic prophylaxis leave many patients at risk for DVT

Pages